PT3393517T - Ácido acetilsalicílico para utilização no tratamento de influenza moderada a grave - Google Patents
Ácido acetilsalicílico para utilização no tratamento de influenza moderada a graveInfo
- Publication number
- PT3393517T PT3393517T PT168230027T PT16823002T PT3393517T PT 3393517 T PT3393517 T PT 3393517T PT 168230027 T PT168230027 T PT 168230027T PT 16823002 T PT16823002 T PT 16823002T PT 3393517 T PT3393517 T PT 3393517T
- Authority
- PT
- Portugal
- Prior art keywords
- moderate
- treatment
- severe influenza
- influenza
- severe
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15202212 | 2015-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3393517T true PT3393517T (pt) | 2021-10-19 |
Family
ID=55022370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT168230027T PT3393517T (pt) | 2015-12-22 | 2016-12-22 | Ácido acetilsalicílico para utilização no tratamento de influenza moderada a grave |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11376265B2 (pt) |
| EP (1) | EP3393517B1 (pt) |
| JP (1) | JP7369523B2 (pt) |
| CN (1) | CN108472375A (pt) |
| AU (1) | AU2016378478B2 (pt) |
| CA (1) | CA3001962C (pt) |
| DK (1) | DK3393517T3 (pt) |
| ES (1) | ES2894330T3 (pt) |
| PT (1) | PT3393517T (pt) |
| WO (1) | WO2017109037A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3044137C (en) * | 2016-12-23 | 2021-06-15 | Ventaleon Gmbh | Improved synthesis of lysine acetylsalicylate · glycine particles |
| KR20220050932A (ko) * | 2019-08-22 | 2022-04-25 | 어플라이드 바이올로지컬 래버러토리즈 인코포레이티드 | 비-스테로이드성 항-염증 약물을 사용한 조성물 및 방법 |
| GB202003722D0 (en) * | 2020-03-14 | 2020-04-29 | Martin John Francis | Treatment |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19851279B4 (de) * | 1998-06-17 | 2006-05-24 | GSF - Forschungszentrum für Umwelt und Gesundheit GmbH | Vorrichtung zum gesteuerten inhalatorischen Einbringen von dosierten Medikamenten in die Lunge |
| DE19912461B4 (de) * | 1999-03-19 | 2006-07-20 | GSF - Forschungszentrum für Umwelt und Gesundheit GmbH | Vorrichtung zur Flußbegrenzung bei niedrigen Differenzdrücken |
| DE10300222A1 (de) * | 2003-01-03 | 2004-07-15 | MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH | Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Viruserkrankungen |
| DE102008004386A1 (de) * | 2008-01-14 | 2009-07-23 | Activaero Gmbh | Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen |
| US8668901B2 (en) * | 2009-02-04 | 2014-03-11 | Activaero Gmbh Research & Development | Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma |
| EP3607941A1 (en) * | 2013-04-30 | 2020-02-12 | Otitopic Inc. | Dry powder formulations and methods of use |
| EP3684338A4 (en) * | 2017-09-22 | 2021-06-23 | Otitopic Inc. | DRY POWDER COMPOSITIONS CONTAINING MAGNESIUM STEARATE |
-
2016
- 2016-12-22 WO PCT/EP2016/082307 patent/WO2017109037A1/en active Application Filing
- 2016-12-22 JP JP2018533677A patent/JP7369523B2/ja active Active
- 2016-12-22 CN CN201680068680.8A patent/CN108472375A/zh active Pending
- 2016-12-22 CA CA3001962A patent/CA3001962C/en active Active
- 2016-12-22 US US16/065,600 patent/US11376265B2/en active Active
- 2016-12-22 ES ES16823002T patent/ES2894330T3/es active Active
- 2016-12-22 DK DK16823002.7T patent/DK3393517T3/da active
- 2016-12-22 PT PT168230027T patent/PT3393517T/pt unknown
- 2016-12-22 AU AU2016378478A patent/AU2016378478B2/en active Active
- 2016-12-22 EP EP16823002.7A patent/EP3393517B1/en active Active
-
2022
- 2022-06-16 US US17/807,184 patent/US20220387455A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20190134066A1 (en) | 2019-05-09 |
| CN108472375A (zh) | 2018-08-31 |
| DK3393517T3 (da) | 2021-11-01 |
| EP3393517A1 (en) | 2018-10-31 |
| JP2019504040A (ja) | 2019-02-14 |
| WO2017109037A1 (en) | 2017-06-29 |
| AU2016378478A1 (en) | 2018-05-10 |
| JP7369523B2 (ja) | 2023-10-26 |
| EP3393517B1 (en) | 2021-08-11 |
| CA3001962C (en) | 2022-09-13 |
| US20220387455A1 (en) | 2022-12-08 |
| ES2894330T8 (es) | 2023-02-14 |
| CA3001962A1 (en) | 2017-06-29 |
| AU2016378478B2 (en) | 2021-11-25 |
| ES2894330T3 (es) | 2022-02-14 |
| US11376265B2 (en) | 2022-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL259110A (en) | Treatment of osteoarthritis (osteoarthritis) | |
| IL283258A (en) | A preparation for the treatment of hypothyroidism | |
| HK1258062A1 (zh) | 給予惡拉戈利的方法 | |
| PL3261721T3 (pl) | Stososowanie pridopidyny w celu poprawy pamięci | |
| IL247354A0 (en) | Treatment of conditions related to excess insulin in the blood | |
| ZA201706257B (en) | Treatment of wood | |
| SG11201609652RA (en) | Treatment of polybacterials infections | |
| IL285882A (en) | Medicinal uses for l–4–chlorokynurenine | |
| HK1244711A1 (zh) | Hmgb1介導的炎症的治療 | |
| PT3334734T (pt) | Forma c de avibactam sódico | |
| HK1231380A1 (zh) | 嚴重高甘油三酯血症的治療 | |
| HK1255221A1 (zh) | 使用卡多曲組合物進行治療的方法 | |
| GB2546139B (en) | Improvements relating to the manufacture of medical devices | |
| IL259781A (en) | Uses of pyrimido-pyridazinones to treat cancer | |
| PT3393517T (pt) | Ácido acetilsalicílico para utilização no tratamento de influenza moderada a grave | |
| HK1246679A1 (zh) | 絲蟲病的治療 | |
| IL249130B (en) | Preparation of piperidine-4-carbothioamide | |
| HUE062134T2 (hu) | Mitokondriális betegségek kezelése | |
| GB201412010D0 (en) | Treatment of hypertransaminasemia | |
| ZA201703153B (en) | Purification of polyphenols | |
| GB201514729D0 (en) | Treatment of haemorrhoids | |
| GB201512139D0 (en) | Methods of treatment | |
| GB201522257D0 (en) | Treatment of autism | |
| GB201512635D0 (en) | Uses of therapeutic compounds | |
| GB201521080D0 (en) | Therapy to increase remyelination |